Cash Flow Daito Pharmaceutical Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
May'24
May'23
May'22
May'21
May'20
May'19
No of Months
12
12
12
12
12
12
Profit Before Tax
4,218.00
5,076.00
6,720.00
5,873.00
5,595.00
4,618.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-1,174.00
-2,457.00
-3,703.00
-2,041.00
-3,424.00
628.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
5,182.00
4,155.00
4,370.00
5,182.00
4,306.00
6,888.00
Cash Flow from Investing Activities
-5,930.00
-5,566.00
-4,332.00
-6,324.00
-2,681.00
-3,867.00
Cash Flow from Financing Activities
-183.00
616.00
921.00
1,424.00
-350.00
-2,898.00
Net Cash Inflow / Outflow
-880.00
-775.00
1,007.00
288.00
1,264.00
107.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
51.00
20.00
48.00
5.00
-9.00
-14.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Daito Pharmaceutical Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(JPY)
Change(%)
Profit Before Tax
4218
-3010.666
7,228.00
240.10%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-1174
-91.032
-1,083.00
-1189.66%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
5182
-3616.711
8,798.00
243.28%
Cash Flow from Investing Activities
-5930
-4.267
-5,926.00
-138873.52%
Cash Flow from Financing Activities
-183
2104.61
-2,287.00
-108.70%
Net Cash Inflow / Outflow
-880
-1536.387
656.00
42.72%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
51
-20.019
71.00
354.76%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - May'24
YoY Growth in year ended May 2024 is 24.72% vs -4.92% in May 2023
May'24
May'23
Change(%)
Cash Flow from Operating Activities
5,182.00
4,155.00
24.72%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
